InspireMD, Inc.
NSPR
22 insider filings · Latest: May 27, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 27, 2026 | May 29 8:05 PM | Paul StukaDirector | Purchase | 20,000 | $0.875 | $17.5K | 667,871(D) | View → |
| May 19, 2026 | May 21 9:16 PM | Shane Thomas GleasonChief Commercial Officer | Sale | 22,778 | $1.01 | $23.0K | 1,053,882(D) | View → |
| Feb 2, 2026 | May 21 9:16 PM | Shane Thomas GleasonChief Commercial Officer | Sale | 2,941 | $1.59 | $4.7K | 1,076,660(D) | View → |
| May 30, 2025 | May 21 9:16 PM | Shane Thomas GleasonChief Commercial Officer | Sale | 7,186 | $2.51 | $18.0K | 1,079,601(D) | View → |
| May 29, 2025 | May 21 9:16 PM | Shane Thomas GleasonChief Commercial Officer | Sale | 3,760 | $2.51 | $9.4K | 1,086,787(D) | View → |
| May 27, 2025 | May 21 9:16 PM | Shane Thomas GleasonChief Commercial Officer | Sale | 1,572 | $2.51 | $3.9K | 1,090,547(D) | View → |
| May 23, 2025 | May 21 9:16 PM | Shane Thomas GleasonChief Commercial Officer | Sale | 2,482 | $2.51 | $6.2K | 1,092,119(D) | View → |
| Feb 25, 2025 | May 21 9:16 PM | Shane Thomas GleasonChief Commercial Officer | Sale | 10,000 | $3.65 | $36.5K | 1,094,601(D) | View → |
| Feb 4, 2025 | May 21 9:16 PM | Shane Thomas GleasonChief Commercial Officer | Sale | 5,132 | $2.46 | $12.6K | 1,104,601(D) | View → |
| Feb 3, 2025 | May 21 9:16 PM | Shane Thomas GleasonChief Commercial Officer | Sale | 7,073 | $2.51 | $17.8K | 1,109,733(D) | View → |
| Jan 31, 2025 | May 21 9:16 PM | Shane Thomas GleasonChief Commercial Officer | Sale | 9,923 | $2.55 | $25.3K | 1,116,806(D) | View → |
| Jan 30, 2025 | May 21 9:16 PM | Shane Thomas GleasonChief Commercial Officer | Sale | 2,454 | $2.51 | $6.2K | 1,126,729(D) | View → |
| Jan 29, 2025 | May 21 9:16 PM | Shane Thomas GleasonChief Commercial Officer | Sale | 3,660 | $2.46 | $9.0K | 1,129,183(D) | View → |
| Jan 28, 2025 | May 21 9:16 PM | Shane Thomas GleasonChief Commercial Officer | Sale | 2,476 | $2.61 | $6.5K | 1,132,843(D) | View → |
| Jan 27, 2025 | May 21 9:16 PM | Shane Thomas GleasonChief Commercial Officer | Sale | 3,858 | $2.71 | $10.5K | 1,135,319(D) | View → |
| May 14, 2026 | May 15 8:05 PM | Paul StukaDirector | Purchase | 5,000 | $1.15 | $5.8K | 647,871(D) | View → |
| May 13, 2026 | May 15 8:05 PM | Paul StukaDirector | Purchase | 10,000 | $1.16 | $11.6K | 642,871(D) | View → |
| May 12, 2026 | May 13 9:00 PM | Marvin SlosmanDirector, CEO and President | Purchase | 21,000 | $1.20 | $25.2K | 3,556,658(D) | View → |
| May 11, 2026 | May 13 8:47 PM | Paul StukaDirector | Purchase | 10,000 | $1.19 | $11.9K | 632,871(D) | View → |
| May 8, 2026 | May 13 8:47 PM | Paul StukaDirector | Purchase | 65,626 | $1.16 | $76.1K | 622,871(D) | View → |
Page 1 of 2
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Dec 30, 2025 | Dec 31 9:15 PM | Kathryn ArnoldDirector | Grant/Award | 26,276 | $1.89 | 111,221(D) | View → |